Pierre Lapalme insider trades: Biomarin Pharmaceutical (BMRN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Pierre reports to the SEC
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 3, 2015 | BMRN | ↓ Sell | 20,000 | $106.57 | $2.1M | Direct | Mar 5, 2015 (2d) |
| May 24, 2013 | INSY | ↑ Buy | 2,000 | $10.39 | $21K | Direct | May 28, 2013 (4d) |
| May 24, 2013 | INSY | ↑ Buy | 1,000 | $10.39 | $10K | By spouse | May 28, 2013 (4d) |
| Feb 26, 2013 | BMRN | ↓ Sell | 29,900 | $55.34 | $1.7M | Direct | Feb 28, 2013 (2d) |
| Feb 28, 2012 | BMRN | ↓ Sell | 20,000 | $36.01 | $720K | Direct | Mar 1, 2012 (2d) |
| Feb 24, 2011 | BMRN | ↓ Sell | 15,100 | $24.95 | $377K | Direct | Feb 24, 2011 (0d) |
| Dec 3, 2008 | BMRN | ↑ Buy | 2,000 | $15.30 | $31K | Direct | Dec 4, 2008 (1d) |
| Dec 3, 2008 | BMRN | ↑ Buy | 400 | $15.29 | $6K | Shares held by spouse. | Dec 4, 2008 (1d) |
| May 23, 2008 | SCRX | ↓ Sell | 3,750 | $21.08 | $79K | Direct | May 28, 2008 (5d) |
| Mar 17, 2008 | SCRX | ↑ Buy | 2,000 | $18.41 | $37K | Direct | Mar 18, 2008 (1d) |
| Feb 29, 2008 | BMRN | ↓ Sell | 9,025 | $37.80 | $341K | Direct | Mar 4, 2008 (4d) |
| Feb 29, 2008 | BMRN | ↓ Sell | 5,975 | $38.43 | $230K | Direct | Mar 4, 2008 (4d) |
| Sep 4, 2007 | SCRX | ↓ Sell | 14,250 | $25.38 | $362K | Direct | Sep 7, 2007 (3d) |
| Dec 12, 2006 | BMRN | ↑ Buy | 2,100 | $17.88 | $38K | Direct | Dec 14, 2006 (2d) |
| Aug 7, 2006 | BMRN | ↑ Buy | 1,000 | $15.35 | $15K | Direct | Aug 8, 2006 (1d) |
| Feb 27, 2006 | BMRN | ↑ Buy | 3,500 | $12.99 | $45K | Direct | Feb 27, 2006 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BMRN insiders
Open-market trades in the last 12 months
About Pierre Lapalme's insider trades
Pierre Lapalme is a director at Biomarin Pharmaceutical (BMRN). Since Feb 27, 2006, Pierre has reported 8 open-market purchases worth $203K and 8 sales worth $5.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (24 filings), option exercises (7 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BMRN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.